These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24865991)
1. Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis. Yang X; Guo Y; Du Y; Yang J; Li S; Liu S; Li K; Zhang D PLoS One; 2014; 9(5):e97460. PubMed ID: 24865991 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis. Li S; Yang X; Yang J; Zhen J; Zhang D Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467 [TBL] [Abstract][Full Text] [Related]
3. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis. Zeng Z; Wang J; Zhao L; Hu P; Zhang H; Tang X; He D; Tang S; Zeng Z PLoS One; 2013; 8(9):e73278. PubMed ID: 24023850 [TBL] [Abstract][Full Text] [Related]
4. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Xu F; Xu L; Wang M; An G; Feng G Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA-195 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis. Liu Y; Tang D; Zheng S; Su R; Tang Y Int J Clin Exp Pathol; 2019; 12(11):3982-3991. PubMed ID: 31933794 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis. Wang H; Xu J; Ding L Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis. Tao S; Ju X; Zhou H; Zeng Q Int J Biol Markers; 2020 Dec; 35(4):51-60. PubMed ID: 33103527 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies. Chen L; Jin H Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397 [TBL] [Abstract][Full Text] [Related]
9. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis. Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis. Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis. Cheng D; Sun Y; He H Dis Markers; 2015; 2015():352670. PubMed ID: 25873748 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer. Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507 [TBL] [Abstract][Full Text] [Related]
13. The accuracy of microRNA-210 in diagnosing lung cancer: a systematic review and meta-analysis. Yang H; Wang H; Zhang C; Tong Z Oncotarget; 2016 Sep; 7(39):63283-63293. PubMed ID: 27557519 [TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer. Wang S; Chen X; Tang M Tumour Biol; 2014 Aug; 35(8):7897-904. PubMed ID: 24828013 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis. Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602 [TBL] [Abstract][Full Text] [Related]
16. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. Zhang L; Cao D; Tang L; Sun C; Hu Y Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis. Qiu L; Weng G J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis. Cheng L; Li Q; Tan B; Ma D; Du G Medicine (Baltimore); 2021 Dec; 100(48):e28061. PubMed ID: 35049226 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer. Liu T; Yin L; Yan G; Li C; Wang L Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]